proviron cycle

Clinical trials of the vaccine ¬†showed high efficacy. Antibodies against measles were detected in 98%, mumps virus in 96.1%, and rubella in 99.3% of vaccinees. One year after vaccination all remained seropositive protective titers of antibodies to measles and rubella, and 88.4% for mumps virus. A certain degree of protection against measles may be achieved by the introduction of non-immune persons in the vaccine within 72 hours after contact with the patient measles. CONTRAINDICATIONS An allergic reaction to the preceding administration of the drug; Hypersensitivity proviron cycle¬†to neomycin, to any…

Read More